作者
Wendaline M. VanBuren,Myra Feldman,Anuradha S. Shenoy-Bhangle,Michelle D. Sakala,Scott W. Young,Luciana Pardini Chamié,Linda C. Giudice,Nicole Hindman,Angela Tong,Joseph T. Rabban,Motoyo Yano,Aoife Kilcoyne,H. Dave,Liina Pōder,Rosanne M. Kho,Tatnai L. Burnett,Zaraq Khan,Cara R. King,Luyao Shen,Ceylan Çolak,Kristine S. Burk,P Andrieu,Izabela Pires Franco,Phyllis Glanc,Ania Z. Kielar,Myles T. Taffel,Leann Kania,Apurva Bonde,Melina Pectasides,Hina Arif‐Tiwari,Sherelle Laifer‐Narin,Refky Nicola,Priyanka Jha
摘要
Endometriosis is a common condition impacting approximately 190 million individuals and up to 50% of women with infertility globally. The disease is characterized by endometrial-like tissue located outside of the uterine corpus, which causes cyclical hemorrhage, inflammation, and fibrosis. Based on clinical suspicion or findings at routine transvaginal pelvic US or other prior imaging, dedicated imaging for endometriosis may be warranted with MRI or advanced transvaginal US. Deep endometriosis (DE) in the pelvis includes evaluation for stromal and fibrotic components and architectural distortion resulting from fibrosis and tethering. It is a disease requiring a compartment-based, pattern-recognition approach. MRI has the benefit of global assessment of the pelvis and is effective in assessing for features of malignancy and for evaluating extrapelvic locations. Transvaginal US has the advantage of dynamic maneuvers to assess for adhesions and may achieve higher spatial resolution for assessing the depth of bowel wall invasion. T1-weighted MRI evaluation increases the specificity of diagnosis by identifying hemorrhagic components, but the presence of T1 signal hyperintensity is not essential for diagnosing DE. Endometriosis is a disease with a broad spectrum; understanding the mild through advanced manifestations, including malignancy evaluation, is within the scope and breadth of radiologists' interpretation.